NEUROLEPTIC MALIGNANT SYNDROME, A RISK FACTOR IN MALIGNANT HYPERTHERMIA

被引：0
|
作者：
MITTERSCHIFFTHALER, G [1 ]
HACKL, JM [1 ]
NEUMANN, R [1 ]
机构：
[1] UNIV INNSBRUCK, PSYCHIAT KLIN, A-6020 INNSBRUCK, AUSTRIA
来源：
ANAESTHESIST | 1989年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：210 / 213
页数：4
相关论文
共 50 条
  • [31] The Nature of Hyperthermia in Neuroleptic Malignant Syndrome and the Use of Bromocriptine
    Gillman, P. Ken
    JOURNAL OF MEDICAL TOXICOLOGY, 2010, 6 (02) : 272 - 273
  • [32] The Nature of Hyperthermia in Neuroleptic Malignant Syndrome and the Use of Bromocriptine
    P. Ken Gillman
    Journal of Medical Toxicology, 2010, 6 (2) : 272 - 273
  • [33] Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma
    Portel, L
    Hilbert, G
    Gruson, D
    Favier, JC
    Gbikpi-Benissan, G
    Cardinaud, JP
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1999, 43 (01) : 107 - 110
  • [34] NEUROLEPTIC MALIGNANT SYNDROME (DOPAMINE-DEPENDENT MALIGNANT HYPERTHERMIA) - 4 CASES
    TRUONG, DD
    SCZESNI, B
    FAHN, S
    GROSS, J
    DONOVAN, K
    VANBAKEL, A
    WILEY, MK
    NERVENARZT, 1988, 59 (02): : 103 - 109
  • [35] AT RISK GROUP FOR NEUROLEPTIC MALIGNANT SYNDROME
    OBRIEN, P
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1988, 33 (09): : 872 - 873
  • [36] NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT HYPERTHERMIA - INVITRO COMPARISON WITH HALOTHANE AND CAFFEINE CONTRACTURE TESTS
    KRIVOSICHORBER, R
    ADNET, P
    GUEVART, E
    THEUNYNCK, D
    LESTAVEL, P
    BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (12) : 1554 - 1556
  • [37] The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders?
    Ortiz, Juan Fernando
    Wirth, Martin
    Eskander, Noha
    Cozar, Jazmin Carolina
    Fatade, Olumuyiwa
    Rathod, Bindu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [38] HOW MALIGNANT IS THE NEUROLEPTIC MALIGNANT SYNDROME
    BRISTOW, MF
    KOHEN, D
    BRITISH MEDICAL JOURNAL, 1993, 307 (6914): : 1223 - 1224
  • [39] NEUROLEPTIC MALIGNANT SYNDROME - RISK-FACTORS
    QURESHI, NA
    ANNALS OF SAUDI MEDICINE, 1993, 13 (01) : 106 - 107
  • [40] Clinical risk factors for neuroleptic malignant syndrome
    Berardi, D
    Dell'Atti, M
    Amore, M
    De Ronchi, D
    Ferrari, G
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (02) : 99 - 102
12345